Buzzetti, R., Maddaloni, E., Gaglia, J., Leslie, R
Dehydration and electrolyte imbalance represent the most plausible explanation
Before buying, he asks suppliers to provide certificates of analysis and endotoxin reports
Novo in October 2024 took the extra step of arguing to the FDA that semaglutide is too complex to compound, asking the regulator to include the drug in its Demonstrable Difficulties for Compounding (DDC) listin turn keeping it out of reach for compounders even in times of shortage
Optimized body composition Mechanisms: Reduce body fat while preserving muscle Improve strength-to-weight ratio Better leverage and force application Enhanced muscle definition Peptides in this category: Growth hormone peptides (recomposition) AOD 9604 (fat loss without muscle loss) Semaglutide/Tirzepatide (weight management) Result: Leaner body = better relative strength and power output